
ENDRA Life Sciences NDRA
€ 2.93
-2.03%
Quartalsbericht 2025-Q3
hinzugefügt 14.11.2025
Land |
|
IPO-Jahr |
2017 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
537 K |
Marktkapitalisierung |
$ 1.81 M |
EBITDA (LTM) |
$ -7.08 M |
P/E (LTM) |
-0.29 |
P/S (LTM) |
5.28 |
EPS (LTM) |
-11.77 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.7 | - | $ 7.46 M | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 123.36 | -0.78 % | $ 19.6 B | Nasdaq Global Select Market,SPB | ||
|
Biomerica
BMRA
|
$ 2.14 | -2.28 % | $ 4.92 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Brainsway Ltd.
BWAY
|
$ 13.68 | 0.15 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Lantheus Holdings
LNTH
|
$ 76.1 | -0.44 % | $ 5.14 B | Nasdaq Global Select Market,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Fulgent Genetics
FLGT
|
$ 16.23 | 4.64 % | $ 491 M | Nasdaq Global Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 104.91 | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.71 | 2.73 % | $ 436 M | Nasdaq Global Select Market,SPB | ||
|
NeoGenomics
NEO
|
$ 8.12 | 2.01 % | $ 1.04 B | Nasdaq Global Select Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
National Research Corporation
NRC
|
$ 17.22 | -0.61 % | $ 385 M | Nasdaq Global Select Market | ||
|
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
- | - | $ 19.5 B | Nasdaq Global Select Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
OPKO Health
OPK
|
- | - | $ 777 M | Nasdaq Global Select Market | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 156.92 | 2.22 % | $ 7.78 B | NYSE,SPB | ||
|
IQVIA Holdings
IQV
|
$ 167.86 | 1.07 % | $ 28.9 B | NYSE,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Personalis
PSNL
|
$ 7.52 | 3.64 % | $ 446 M | Nasdaq Global Select Market | ||
|
IDEXX Laboratories
IDXX
|
$ 581.5 | 0.73 % | $ 46.8 B | Nasdaq Global Select Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
BioNano Genomics
BNGO
|
$ 1.33 | 15.65 % | $ 1.69 M | Nasdaq Capital Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 459.18 | 1.47 % | $ 13.2 B | Nasdaq Global Select Market,SPB | ||
|
Senseonics Holdings
SENS
|
$ 6.7 | 3.4 % | $ 280 M | NYSE American | ||
|
Agilent Technologies
A
|
$ 112.09 | 0.73 % | $ 34.1 B | NYSE,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 101.04 | 1.34 % | $ 8.33 B | Nasdaq Global Select Market,SPB | ||
|
Sotera Health Company
SHC
|
$ 13.97 | 3.44 % | $ 3.97 B | Nasdaq Global Select Market | ||
|
DarioHealth Corp.
DRIO
|
$ 7.99 | - | $ 31.8 M | Nasdaq Capital Market | ||
|
Guardant Health
GH
|
$ 85.5 | 0.38 % | $ 10.7 B | Nasdaq Global Select Market,SPB | ||
|
Soleno Therapeutics
SLNO
|
$ 32.33 | -2.68 % | $ 1.64 B | Nasdaq Capital Market | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Neuronetics
STIM
|
$ 1.58 | 8.81 % | $ 104 M | Nasdaq Global Select Market | ||
|
Mettler-Toledo International
MTD
|
$ 1 241.31 | 3.1 % | $ 25.6 B | NYSE,SPB | ||
|
CareDx, Inc
CDNA
|
$ 17.57 | 2.45 % | $ 936 M | Nasdaq Global Market,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 478.95 | 0.93 % | $ 181 B | NYSE,SPB | ||
|
Bioventus
BVS
|
$ 9.05 | 4.75 % | $ 603 M | Nasdaq Global Select Market | ||
|
Celcuity
CELC
|
$ 107.05 | 0.95 % | $ 4.22 B | Nasdaq Global Select Market |